|
1 | HRCS Health |
| Cancer and neoplasms |
2 | HRCS Health |
| Eye |
3 | HRCS Health |
| Generic Health Relevance |
4 | HRCS Health |
| Infection |
5 | HRCS Health |
| Inflammatory and Immune System |
6 | HRCS Health |
| Mental Health |
7 | HRCS Health |
| Reproductive Health and Childbirth |
8 | HRCS Health |
| Respiratory |
9 | HRCS RAC | 4. Detection, Screening and Diagnosis | 4.2 Evaluation of markers and technologies |
10 | HRCS RAC | 4. Detection, Screening and Diagnosis | 4.4 Population screening |
11 | HRCS RAC | 5. Development of Treatments and Therapeutic Interventions | 5.2 Cellular and gene therapies |
12 | HRCS RAC | 5. Development of Treatments and Therapeutic Interventions | 5.3 Medical devices |
13 | HRCS RAC | 5. Development of Treatments and Therapeutic Interventions | 5.6 Psychological and behavioural |
14 | HRCS RAC | 5. Development of Treatments and Therapeutic Interventions | 5.7 Physical |
15 | HRCS RAC | 5. Development of Treatments and Therapeutic Interventions | 5.8 Complementary |
16 | HRCS RAC | 6. Evaluation of Treatments and Therapeutic Interventions | 6.1 Pharmaceuticals |
17 | HRCS RAC | 6. Evaluation of Treatments and Therapeutic Interventions | 6.6 Psychological and behavioural |
18 | HRCS RAC | 8. Health and Social Care Services Research | 8.2 Health and welfare economics |
19 | HRCS RAC | 8. Health and Social Care Services Research | 8.3 Policy, ethics and research governance |
20 | HRCS RAC | 9. Awaiting RAC Coding | 9.1 Awaiting RAC Coding |
21 | HRCS Health |
| Cardiovascular |
22 | HRCS Health |
| Congenital Disorders |
23 | HRCS Health |
| Disputed aetiology and other |
24 | HRCS Health |
| Injuries and Accidents |
25 | HRCS Health |
| Metabolic and Endocrine |
26 | HRCS Health |
| Oral and Gastrointestinal |
27 | HRCS Health |
| Skin |
28 | HRCS RAC | 1. Underpinning Research | 1.1 Normal biological development and functioning |
29 | HRCS RAC | 1. Underpinning Research | 1.2 Psychological and socioeconomic processes |
30 | HRCS RAC | 1. Underpinning Research | 1.5 Resources and infrastructure (underpinning) |
31 | HRCS RAC | 2. Aetiology | 2.1 Biological and endogenous factors |
32 | HRCS RAC | 2. Aetiology | 2.2 Factors relating to physical environment |
33 | HRCS RAC | 2. Aetiology | 2.4 Surveillance and distribution |
34 | HRCS RAC | 2. Aetiology | 2.5 Research design and methodology (aetiology) |
35 | HRCS RAC | 3. Prevention of Disease and Conditions, and Promotion of Well-Being | 3.1 Primary prevention interventions to modify behaviours or promote well-being |
36 | HRCS RAC | 3. Prevention of Disease and Conditions, and Promotion of Well-Being | 3.3 Nutrition and chemoprevention |
37 | HRCS RAC | 3. Prevention of Disease and Conditions, and Promotion of Well-Being | 3.4 Vaccines |
38 | HRCS RAC | 4. Detection, Screening and Diagnosis | 4.1 Discovery and preclinical testing of markers and technologies |
39 | HRCS RAC | 4. Detection, Screening and Diagnosis | 4.3 Influences and impact |
40 | HRCS RAC | 5. Development of Treatments and Therapeutic Interventions | 5.5 Radiotherapy |